Editorial Policies

Focus and Scope

J.Pharm.Sci.Community publishes original, previously unpublished research articles, review articles, as well as short communication in various pharmaceutical fields. Paper topics include the following:

  • Pharmaceutical Technology and Pharmaceutics
  • Pharmaceutical Analysis
  • Medicinal Chemistry
  • Pharmacology and Toxicology
  • Pharmaceutical Biology and Biotechnology
  • Pharmacognosy and Phytochemistry
  • Social Behavior and Administrative Pharmacy
  • Pharmacoeconomics
  • Clinical Pharmacy
  • Other pharmaceutical topics

 

 

Section Policies

Articles

Checked Open Submissions Checked Indexed Checked Peer Reviewed
 

Open Access Policy

This journal provides immediate open access to its content on the principle that making research freely available to the public supports a greater global exchange of knowledge.

 

Archiving

This journal utilizes the LOCKSS system to create a distributed archiving system among participating libraries and permits those libraries to create permanent archives of the journal for purposes of preservation and restoration. More...

 

Publication Ethics and Malpractice Statement

Journal of Pharmaceutical Sciences and Community is a peer-reviewed journal. It is necessary to agree upon standards of expected ethical behavior for all parties involved in the act of publishing: the author, the journal editor, the peer reviewer and the publisher. This statement is based on Practice Guidelines for publication as in Committee on Publication Ethics (COPE’s Best).

In addition, every full paper submitted to J. Pharm. Sci. Community  will be screened using Turnitin (an Internet-based plagiarism-prevention service) to detect the possibilities of plagiarism.

 

AUTHORS

Reporting Standard

  • Authors are expected to have made reasonable attempts to check and validate results submitted to the journal for publication.
  • Authors should provide real and authentic research data.
  • Authors should confirm that the journal is not published in another journal.
  • Authors are required to cite the sources correctly by considering the content of the manuscript either in the form of written publications and personal interviews.

 

Originality and plagiarism

The authors should confirm that they have written entirely original works, and if the authors have used the work and/or words of others that this has been appropriately cited or quoted.

 

Multiple, Redundant, or Concurrent Publication

Authors should not submit or publish the same manuscript to more than one journal or primary publication.

 

Authorship of the Paper

  • Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported research.
  • All those who have made significant contributions should be listed as co-authors.
  • Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.

 

Hazards and Human or Animal Subjects

If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) has approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

 

Data Access and Retention

Authors may be asked to provide the raw data in connection with a paper for editorial review, and should in any event be prepared to keep such data for a reasonable time after publication.

 

Disclosure and Conflicts of Interest

  • All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript.
  • All sources of financial support for the project should be disclosed.

 

Fundamental errors in published works

  • When an author discovers a significant error or inaccuracy in his/her own published work, it is the author's obligation to promptly notify the journal editor or publisher and cooperate with the editor to retract or correct the paper.
  • If the editor or the publisher learns from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper or provide evidence to the editor of the correctness of the original paper.

 

EDITORS

Fair Play

An editor assesses manuscripts based only on the originality and the quality of the paper and should not be affected by the religious, national, political or any other influences.

 

Confidentiality

The editors and any editorial staff must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

 

Disclosure and Conflicts of Interest

Unpublished materials disclosed in a submitted manuscript must not be used in editors' own research without the express written consent of the author.

 

PEER REVIEWERS

Contribution to Editorial Decisions

  • Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author to give proper assessment and judgement of the submitted paper.
  • Reviewers should immediately inform the editor if any form of plagiarism is identified within submitted work.

 

Promptness

Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editors and excuse himself from the review process.

 

Confidentiality

Any manuscripts received for review must be treated as confidential documents. They must not be shown to, or discussed with others except as authorized by the editor.

 

Standards of Objectivity

Reviews should be conducted objectively. Personal criticism of the author is inappropriate. The reviewers should express their views clearly with supporting rationale arguments.

 

Acknowledgement of Sources

  • Reviewers should point out on relevant published work which is not cited in the article.
  • Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation.
  • A reviewer should also call to the editor's attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

 

Disclosure and Conflict of Interest

  • Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.
  • Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships with any of the authors or institutions connected to the papers.

 

PUBLISHER

  • J. Pharm. Sci. Community is committed to ensuring that commercial interest has no impact or influence on editorial decisions.
  • J. Pharm. Sci. Community will assist in communications with other journals where this is useful to the authors.
  • J. Pharm. Sci. Community is working closely with all related divisions to set standards for best practices on ethical matters, errors and retractions--and are prepared to provide specialized legal review and counsel if necessary.

 

 

 

Publication Frequency

Journal of Pharmaceutical Sciences and Community is published by Faculty of Pharmacy, Universitas Sanata Dharma. J. Pharm. Sci. Community is published twice every year (May and November).

 

Review Process

J. Pharm. Sci. Community uses double-blind review, which means that both the reviewer and author identities are concealed from the reviewers, and vice versa, throughout the review process. The review process is expected to take two (2) to three (3) months but it may take longer depending on the number of papers currently being reviewed. The following are the four main steps of the review process.

  1. The completed manuscript uploaded by the author(s) to the J. Pharm. Sci. Community website is then assigned by the Section Editor to see the editorial process.
  2. The editor will invite reviewers to give proper assessment and judgement of the submitted manuscript.
  3. The result of the review will be communicated to the editor for onward transmission to the author(s).
  4. If required, the author(s) will revise the manuscript in light of the reviewers’ comments and suggestions and resubmit the manuscript within two to six weeks. When the manuscript is finally accepted for publication, the editor will schedule the publication and inform the author(s) of the particular number and volume of the journal in which the article will be published. 

 

Plagiarism Screening

Every full paper submitted to J. Pharm. Sci. Community  will be screened using Turnitin (an Internet-based plagiarism-prevention service) to detect the possibilities of plagiarism.

 

Article Submission Charges

Article submission in J. Pharm. Sci. Community is free of charge; there are no article submission charges (without any ASCs).

 

Article Processing Charges

Article processing in J. Pharm. Sci. Community is free of charge; there are no article processing charges (without any APCs).

 

Journal Subscription (Hard copy)

All orders for hardcopy of the journal may be sent via email to editorial.jpsc@usd.ac.id with the subject Order Journal. The price of an issue is IDR 100,000.00. The price is not included the packaging and postal delivery fees to the address of the subscribers. 

Payments should be performed via transfer to CIMB Niaga  (Account holder: Lembaga Penelitian Univ. Sanata Dharma, Account Nr. 800077540800).

The order will be executed when payment have been performed and the proof of payment has been scanned and sent accordingly.

 

Licensing

J. Pharm. Sci. Community allows reuse and remixing of its content, in accordance with a CC BY. This license lets others distribute, remix, tweak, and build upon your work, even commercially, as long as they credit you for the original creation. 

Creative Commons Licence
This work is licensed under a Creative Commons Attribution 4.0 International License.